These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 23593253)
21. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans. Wahid R; Fresnay S; Levine MM; Sztein MB Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480 [TBL] [Abstract][Full Text] [Related]
22. Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever. Cross DL; Verheul MK; Leipold MD; Obermoser G; Jin C; Jones E; Starr JS; Mohorianu I; Blohmke CJ; Maecker HT; Napolitani G; Hill J; Pollard AJ Front Immunol; 2020; 11():574057. PubMed ID: 33424833 [TBL] [Abstract][Full Text] [Related]
23. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever. Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110 [TBL] [Abstract][Full Text] [Related]
24. Vaccines for preventing typhoid fever. Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413 [TBL] [Abstract][Full Text] [Related]
25. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. Salerno-Goncalves R; Pasetti MF; Sztein MB J Immunol; 2002 Aug; 169(4):2196-203. PubMed ID: 12165550 [TBL] [Abstract][Full Text] [Related]
26. Development of a synthetic Vi polysaccharide vaccine for typhoid fever. Ni Y; Springer MJ; Guo J; Finger-Baker I; Wilson JP; Cobb RR; Turner D; Tizard I Vaccine; 2017 Dec; 35(51):7121-7126. PubMed ID: 29150208 [TBL] [Abstract][Full Text] [Related]
27. Differential functional patterns of memory CD4 Salerno-Gonçalves R; Tettelin H; Luo D; Guo Q; Ardito MT; Martin WD; De Groot AS; Sztein MB Vaccine; 2020 Jan; 38(2):258-270. PubMed ID: 31629569 [TBL] [Abstract][Full Text] [Related]
28. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a. Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309 [TBL] [Abstract][Full Text] [Related]
29. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Wahid R; Fresnay S; Levine MM; Sztein MB Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430 [TBL] [Abstract][Full Text] [Related]
30. Measurement of Typhi Vi antibodies can be used to assess adaptive immunity in patients with immunodeficiency. Evans C; Bateman E; Steven R; Ponsford M; Cullinane A; Shenton C; Duthie G; Conlon C; Jolles S; Huissoon AP; Longhurst HJ; Rahman T; Scott C; Wallis G; Harding S; Parker AR; Ferry BL Clin Exp Immunol; 2018 Jun; 192(3):292-301. PubMed ID: 29377063 [TBL] [Abstract][Full Text] [Related]
31. Role of circulating T follicular helper subsets following Ty21a immunization and oral challenge with wild type Booth JS; Rapaka RR; McArthur MA; Fresnay S; Darton TC; Blohmke CJ; Jones C; Waddington CS; Levine MM; Pollard AJ; Sztein MB Front Immunol; 2024; 15():1384642. PubMed ID: 39328410 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis. Batool R; Qamar ZH; Salam RA; Yousafzai MT; Ashorn P; Qamar FN Lancet Glob Health; 2024 Apr; 12(4):e589-e598. PubMed ID: 38485426 [TBL] [Abstract][Full Text] [Related]
33. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a. Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550 [TBL] [Abstract][Full Text] [Related]
34. Diversity of Salmonella Typhi-responsive CD4 and CD8 T cells before and after Ty21a typhoid vaccination in children and adults. Rudolph ME; McArthur MA; Magder LS; Barnes RS; Chen WH; Sztein MB Int Immunol; 2019 Apr; 31(5):315-333. PubMed ID: 30951606 [TBL] [Abstract][Full Text] [Related]
35. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. Robbins JD; Robbins JB J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249 [TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea. Kim YR; Yoo JH; Hur JK; Kang JH; Shin WS; Kang MW J Korean Med Sci; 1995 Oct; 10(5):314-7. PubMed ID: 8750055 [TBL] [Abstract][Full Text] [Related]
37. Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Wahid R; Zafar SJ; McArthur MA; Pasetti MF; Levine MM; Sztein MB Clin Vaccine Immunol; 2014 Mar; 21(3):427-34. PubMed ID: 24429069 [TBL] [Abstract][Full Text] [Related]
38. Vaccination of active component US military personnel against Salmonella Typhi. Porter CK; Sorrell T; Mitra I; Riddle MS Vaccine; 2017 Mar; 35(14):1742-1748. PubMed ID: 28268075 [TBL] [Abstract][Full Text] [Related]
39. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever. Tacket CO; Levine MM; Robbins JB Vaccine; 1988 Aug; 6(4):307-8. PubMed ID: 3188615 [TBL] [Abstract][Full Text] [Related]
40. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a. Chau PY; Tsang RS Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]